期刊文献+

中国人群家族性高胆固醇血症LDLR基因突变研究进展 被引量:20

Research progression of LDLR mutations in Chinese Familial hypercholesterolemia
下载PDF
导出
摘要 家族性高胆固醇血症(Familial hypercholesterolemia,FH)主要是由于低密度脂蛋白受体(Low-density lipoprotein receptor,LDLR)基因突变导致的单基因显性遗传性疾病。FH患者LDLR基因突变导致细胞膜表面LDLR减少或缺如,机体代谢胆固醇能力降低,血浆胆固醇增高并沉积在不同的组织和器官,常伴有全身黄色瘤和早发冠心病,因此FH也是最常见的严重代谢性疾病。世界范围内对LDLR基因突变的报道总共有1741种,经整理我国目前报道的140例FH指示病例,包括108种LDLR基因突变类型。文章对已报道的中国FH患者LDLR基因突变特点进行系统分析和综述,旨在为FH诊断治疗提供参考依据。 Familial hypercholesterolemia(FH),one monogenic autosomal dominant disease,mainly results from genetic defects in the low-density lipoprotein receptor(LDLR) gene,which leads to the reduction or absence of cell surface LDLR,disorder of cholesterol metabolism,and cholesterol deposition in different tissues and organs.FH is a common metabolic disease clinically characterized by the presence of xanthomas and premature coronary heart disease.To date,about 1 741 variants have been identified in gene LDLR,among which 108 variants were identified in Chinese FH patients.To better understand the features of LDLR gene mutations and help to FH diagnosis and therapy,this review provides a comprehensive overview of LDLR gene mutations in Chinese FH patients.
出处 《遗传》 CAS CSCD 北大核心 2011年第1期1-8,共8页 Hereditas(Beijing)
基金 国家自然科学基金项目(编号:30771986,30772356) 北京市自然科学基金项目(编号:7062010,7092016)资助
关键词 高胆固醇血症 家族性 低密度脂蛋白受体 基因突变 中国人群 hypercholesterolemia familial low-density lipoprotein receptor gene mutation Chinese
  • 相关文献

参考文献19

二级参考文献152

共引文献50

同被引文献180

  • 1许国强,陈洪潭,厉有名,金恩芸,陈李华,张冰凌.易成石和抗成石小鼠肝脏胆固醇代谢调节酶的基因表达特征[J].中华消化杂志,2005,25(3):157-161. 被引量:4
  • 2周瑜琳,赵咏桔,崔斌,罗邦尧,朱鋐达,顾雪疆,李小英,宁光.家族性高胆固醇血症黄色瘤的家系遗传分析[J].诊断学理论与实践,2005,4(6):473-476. 被引量:4
  • 3廉馨,王绿娅,尹卫东.他汀类药物在家族性高胆固醇血症治疗中的应用[J].中国动脉硬化杂志,2006,14(4):359-362. 被引量:1
  • 4Sibley C, Stone NJ. Familial hypercholesterolemia:A challenge of diagnosis and therapy. Cleve Clin J Med, 2006,73:57-64.
  • 5Wang L, Lin J, Liu S, et al. Mutations in the LDL receptor gene in four Chinese homozygons familial hypercholesterolemia phenotype patients. Nutrition, Metabolism and Cardiovascular Diseases, 9009,19 : 391-400.
  • 6Chen K, Mu YM, Wang BA, et al. Two novel mutations 685del land D129G in the low-density lipoprotein receptor gene in a compound heterozygote Chinese family with familial hypercholesterolemia. Metabolism, 2007,56:636-640.
  • 7Innerarity TL, Mahley RW, Weisgraber KH, et al. Familial defective apolipoprotein B-100:a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res, 1990,31: 1337-1349.
  • 8Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat Genet, 2003,34: 154-156.
  • 9Damgaard D, Jensen JM, Larsen ML, et al. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYPTA1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes. Atherosclerosls, 2004,177:415-422.
  • 10Saint Jore B, Varret M, Dachet C, et al. Autosomal dominant type Ⅱ a hypercholesterolemia: evaluation of the respective contributions of LDL-R and apoB gene defects as well as a third major group of defects. Eur J Hum Genet, 2000,8:621-630.

引证文献20

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部